0002099941-25-000001.txt : 20251210 0002099941-25-000001.hdr.sgml : 20251210 20251210123044 ACCESSION NUMBER: 0002099941-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251210 DATE AS OF CHANGE: 20251210 EFFECTIVENESS DATE: 20251210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amani Therapeutics, Inc. CENTRAL INDEX KEY: 0002099941 ORGANIZATION NAME: EIN: 393302644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566363 FILM NUMBER: 251561372 BUSINESS ADDRESS: STREET 1: 40 10TH AVENUE STREET 2: FLOOR 7 CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (646) 597-6980 MAIL ADDRESS: STREET 1: 40 10TH AVENUE STREET 2: FLOOR 7 CITY: NEW YORK STATE: NY ZIP: 10014 D 1 primary_doc.xml X0708 D LIVE 0002099941 Amani Therapeutics, Inc. 40 10TH AVENUE FLOOR 7 NEW YORK NY NEW YORK 10014 (646) 597-6980 DELAWARE None None Corporation true 2025 Alice Lee 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Executive Officer Director -- RTW Holdings VI, LLC 40 10th Avenue Floor 7 New York NY NEW YORK 10014 Promoter Other Health Care Decline to Disclose 06b false 2025-11-25 false true false 0 31120000 31120000 0 false 2 0 0 0 false Amani Therapeutics, Inc. Alice Lee Alice Lee President 2025-12-08